Middle meningeal artery embolization for migraine: A review
Surgical Neurology International · 14.11.2025 · 16 · 475
DOI: 10.25259/sni_651_2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Neurology International, online erschienen am 14.11.2025. Verfasst von Deborah Boyett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Columbia University Irving Medical Center, Columbia University, New York, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Migraine and chronic headaches are highly prevalent disorders representing billions in healthcare spending and significantly reduced quality of life. The middle meningeal artery (MMA) is an established target in intracranial pathologies, and MMA embolization may be an innovative and promising therapeutic approach in the management of chronic headaches.
Methods
This review of the literature aims to provide an in-depth analysis of the current state of knowledge regarding the effectiveness, safety, and potential implications of surgical targeting of the MMA, with particular emphasis on MMA embolization in the treatment of migraines and chronic headaches. PubMed was systematically queried for studies of MMA Embolization for the treatment of headache.
Results
The trigeminovascular system is uniquely implicated in the pathogenesis of migraine headaches. Significant improvement in symptoms has been shown when targeting the neural, chemical, and vascular components of this system. The MMA has demonstrated unique behavior during and after migraines, distinct from that of other intracranial vessels. Reports of MMA perturbance have demonstrated prolonged improvements in migraine-induced pain without major adverse effects.
Conclusion
The MMA’s unique role in the pathophysiology of migraines renders it a unique target for therapeutic intervention. Early studies revealing clinical migraine benefit after MMA disruption underscore the potential therapeutic value of MMA embolization. MMA embolization has been demonstrated to be safe and feasible.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, Columbia University Irving Medical Center, Columbia University, New York, United States.
- Department of Neurology, Columbia University Irving Medical Center, Columbia University, New York, United States.
Zitieren
APA
Boyett, D., Khoury, N. M., Shlobin, N., Yugrakh, M. S., Lavine, S., & Mandigo, G. K. (2025). Middle meningeal artery embolization for migraine: A review. Surgical Neurology International, 16, 475. https://doi.org/10.25259/sni_651_2025
Vancouver
Boyett D, Khoury NM, Shlobin N, Yugrakh MS, Lavine S, Mandigo GK. Middle meningeal artery embolization for migraine: A review. Surgical Neurology International. 2025;16:475. doi:10.25259/sni_651_2025
BibTeX
@article{Boyett2025,
author = {Boyett, Deborah and Khoury, Nadine Marie and Shlobin, Nathan and Yugrakh, Marianna Shnayderman and Lavine, Sean and Mandigo, Grace Kim},
title = {Middle meningeal artery embolization for migraine: A review},
journal = {Surgical Neurology International},
year = {2025},
volume = {16},
pages = {475},
doi = {10.25259/sni_651_2025}
}
EUVIMED